ProAliFun_6.7_Health Effects of a Low-Salt Bread on Hypertensive Subjects (ProAliFun67)

Technological and Clinical Innovative Protocols for the Production of Functional Foods - 6.7 (ProAliFun67)

The purpose of this clinical study is to evaluate the health properties of a dietary intervention carried on with an innovative low-salt bread.

The hypothesis is that the introduction of a low-sodium bread as part of a low-salt diet may improve the compliance to the own regime and that the vascular function, the inflammatory and oxidative state, the composition of the intestinal microbiota and that neurocognitive and neurodegenerative processes can improve in hypertensive patients fed a low-salt diet with low-salt bread.

Study Overview

Detailed Description

This clinical trial is a multi-center, randomized, controlled, open label, pilot study, lasting 6 months.

A target number of seventy individuals with hypertension meeting inclusion and exclusion criteria, assessed at enrollment, and which have signed the informed consent, will be recruited.

Study Type

Interventional

Enrollment (Actual)

57

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • BA
      • Bari, BA, Italy, 70125
        • AUO Policlinico Consorziale

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • arterial hypertension stage I-II
  • stable control of blood pressure
  • eGFR > 60
  • informed consent signed

Exclusion Criteria:

  • uncontrolled hypertension
  • therapy with diuretics
  • need for therapy with more than three antihypertensive drugs
  • proteinuria greater than 1 g/day
  • celiac disease
  • systemic inflammatory diseases
  • suspicion or clinical diagnosis of malignancy
  • chronic liver disease
  • treatment with corticosteroids or immunosuppressive drugs
  • previous acute cardiovascular diseases (myocardial infarction, stroke)
  • psychiatric conditions reducing the compliance to treatment protocols

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: A - control
Free diet with standard bread
Active Comparator: B - low-salt diet with normal bread
Low-sodium diet with standard bread
low-sodium diet (2300 mg Na/die) with use of standard bread (750 mg Na/100g) for 6 months
Experimental: C - low-salt diet with low-salt bread
Low-sodium diet with low-sodium bread
low-sodium diet (2300 mg Na/die) with use of low-salt bread (280 mg Na/100g) for 6 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sodium intake
Time Frame: 6 months
Reduction of sodium intake in diet with the introduction of the innovative formulation of low-salt bread
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure
Time Frame: 6 months
Reduction of blood pressure
6 months
Endothelial stress
Time Frame: 6 months
Improvement of flow-mediated dilation FMD
6 months
Gut microbiota
Time Frame: 6 months
Evaluation of gut microbiota modulation
6 months
Antioxidant status
Time Frame: 6 months
Evaluation of the antioxidant/oxidant ratio of blood
6 months
Inflammation
Time Frame: 6 months
State of sub-clinical inflammation
6 months
Insulin sensitivity
Time Frame: 6 months
Reduction of insulin sensitivity
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2014

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

April 10, 2017

First Submitted That Met QC Criteria

April 20, 2017

First Posted (Actual)

April 25, 2017

Study Record Updates

Last Update Posted (Actual)

April 25, 2017

Last Update Submitted That Met QC Criteria

April 20, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ProAliFun_6.7_CE4373

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Low-sodium diet with standard bread

Subscribe